Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product Type, Technology & Application The global lateral flow assays market will witness a robust CAGR of 4.34%, valued at $8.76 billion in 2021, expected to appreciate and reach $12.85 billion by 2030, confirms Strategic Market Research. The North American region had the highest share of the market for lateral flow assay, accounting for 36.3% of revenue in 2020. The lateral flow assay (LFA) is a paper-based platform for detecting and quantifying analytes in complex mixtures. The sample is placed on a test device, and the results are shown within 5 to 30 minutes. Market Drivers - High Prevalence of the Infectious Disease Worldwide, Rapidly Rising Geriatric Population, Increasing use of Home-based Lateral Flow Assay Devices, Rising Demand for POC devices, Need for Rapid Diagnostic Testing for COVID-19 Despite major advances in medicine and sanitation, the global prevalence of infectious illnesses remains high. Although non-communicable illnesses are the largest cause of morbidity and death, infectious diseases continue to be a major public health problem worldwide. As per a study by the National Institute of Allergy and Infectious Diseases, infectious illnesses take around 15 million lives worldwide each year. The high incidence of contagious illnesses such as HIV and malaria, poor healthcare infrastructure, and raising public awareness is projected to increase the use of lateral flow assay testing in developing nations. Chronic illnesses such as cystic fibrosis, cardiovascular ailments, hepatitis, and cancer are frequently caused by age-related physiological changes and metabolic problems. Due to low immune systems, geriatric people are more prone to various disorders and infections. The global growth in the senior population, along with a rising patient pool for chronic illnesses, is augmenting the lateral flow assays market growth extensively. Home-based lateral flow assay devices are extremely important in treating cardiovascular and infectious disorders. These devices are also particularly beneficial for detecting pregnancy and stigmatised diseases such as HIV. In addition, they may allow patients to do self-tests from the comfort of their own homes. As a result, the rising prevalence of these illnesses and the increased use of lateral flow assay tests in-home care settings are predicted to drive up the global demand for lateral flow assays. Currently, the majority of diagnostic tests conducted throughout the world are laboratory-based. The demand for Point-of-care (POC) diagnostics based on lateral flow assays, on the other hand, is increasing in order to replace time-consuming and traditional laboratory procedures. In addition, POC diagnostic tests need less sophisticated infrastructure and training, resulting in cheaper costs than conventional laboratory diagnostic methods. Because of its relevance in combating an increasing disease burden, point-of-care testing is expected to have the greatest market share in the lateral flow assay industry. Since December 2019, the COVID-19 epidemic has spread over the world. With the number of people infected by the virus increasing, there is a greater demand for simple and rapid diagnostics. Lateral flow assay methods have been designed to identify antibodies (IgM, IgG, or both) to the COVID-19 virus in blood or nasopharyngeal samples from patients. The increased number of COVID-19 cases worldwide and the requirement for early diagnosis for treatment and data collecting are projected to drive the market over the projection period. Market Restraints - Inconsistent Results of Lateral Flow Assay Tests Although easier to perform and less expensive than laboratory testing, lateral flow assay tests are less accurate, limiting the growth of the market during the projection period. Market Opportunities - Evolving Application of Lateral Flow Assay In the last two decades, lateral flow assay has rapidly evolved. It is now commonly utilised in point-of-care and diagnostic applications. Capillary flow and nitrocellulose membrane can be used in lateral flow assay manufacturing. Lateral flow assay is used for point-of-care (POC), pregnancy tests, and infectious disease detection. Antibodies, Membrane, medical, veterinary, food, and agricultural lateral flow assay devices exist in the market. These devices are made necessary by flow cytometry industry analysis. Immunoassay, biosensors, POC diagnostics, ELISA, polymerase chain reaction, electrochemical lateral flow assay, sers-based lateral flow assay, fluorescence lateral flow assay, photothermal lateral flow assay, immunochromatographic assay, Quantitative Lateral Flow Assay and Magnetic Lateral Flow Immunoassay can help in positively shifting the market trends in the future thus catering to ample growth opportunities. Market Analysis Of Different Segments Covered in the Report Based on Product Kits & Reagents Lateral Flow Readers Based on Application Clinical Testing Cardiac Marker Testing Pregnancy and Fertility Testing Cholesterol Testing/Lipid Profile Testing Drugs of Abuse Testing Others Based on Technique Sandwich Assay Competitive Assay Multiplex Detection Assay Based on End-Use Hospitals and Clinics Diagnostic Laboratories Homecare Pharmaceutical and Biotechnology Companies Others Regional Coverage Analysis North America United States of America Canada Rest of North America Europe United Kingdom Germany France Italy Spain Russia Rest of Europe Asia-Pacific Japan China India Australia South Korea Singapore Rest of Asia-Pacific LAMEA Brazil Argentina South Africa Saudi Arabia United Arab Emirates Rest of LAMEA Segments Analysis & Insights The Kits and Reagents segment led the lateral flow assays market, accounting for 67.8% of total revenue. The introduction of new kits by leading players is expected to drive industry expansion over the forecast period. The clinical testing segment led the market for lateral flow tests, accounting for 67.9% of total revenue. This is due to an increase in infectious illnesses, such as the COVID-19 outbreak. The sandwich assay has the largest industry size, accounting for 39.5% of revenue in 2020 due to its accuracy, cost, and convenience of use. The hospitals and clinics segment led the market, accounting for 39.5% of total revenue. Hospitals and clinics are primary care sites for medical diagnosis and treatment. The majority of the population relies on hospitals and clinics for illness diagnosis, treatment, and management. North America has the market share, accounting for 36.3% of sales in 2020. This is due to the availability and inexpensive cost of technologically improved lateral flow tests. However, Asia Pacific is the fastest-growing market over the projection period, with a CAGR of 4.2%. Rising demand as a result of the high prevalence of infectious and chronic illnesses and the introduction of new players in Asian nations are important driving factors for regional industry expansion. Global Lateral flow Assays Market Competitive Landscape Analysis The industry is quite competitive, with a significant number of important competitors and new entrants present. Market growth is stimulated by the introduction of new strategies to retain competitiveness. In addition, the COVID-19 pandemic has increased the number of new market participants, which has increased industry competitiveness. Abbott Laboratories Quidel Corporation F. Hoffman-La Roche AG Danaher Corporation Siemens AG Becton, Dickinson and Company bioMérieux SA Bio-Rad Laboratories Thermo Fisher Scientific, Inc. PerkinElmer Inc. Hologic Inc. QIAGEN N.V. Merck KGaA Lateral Flow Assays Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 8.79 Billion The revenue forecast in 2030 USD 12.85 Billion Growth rate CAGR of approximately 4.34% The base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By End-user, By Technique, By Application, By Region By Product Kits & Reagents, Lateral Flow Readers. By Technique Sandwich Assay, Competitive Assay, Multiplex Detection Assay. By End-user Hospitals and Clinics, Diagnostic Laboratories, Homecare, Pharmaceutical and Biotechnology Companies, Others. By Application Clinical Testing, Cardiac Marker Testing, Pregnancy and Fertility Testing, Cholesterol Testing/Lipid Profile Testing, Drugs of Abuse Testing, Others. By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Abbott Laboratories, Quidel Corporation, F. Hoffman-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Hologic Inc., QIAGEN N.V., Merck KGaA. Recent Developments In August 2021, Becton, Dickinson and Company received permission for the OTC fast antigen test utilising the Scanwell Health Mobile App. This is a quick, digitally read B.D. Created lateral flow antigen self-test to make COVID-19 testing faster and easier for people to do safely at home. In April 2021, Becton, Dickinson and Company (BD) teamed with USA Track & Field (USATF) (U.S.) to provide rapid COVID-19 testing for athletes utilising the BD Veritor plus system. This collaboration aims to assist USATF professional athletes in returning to competition safely. In September 2020, Qiagen N.V. bought NeuMoDx Molecular, Inc. to expand Qiagen's diagnostics instrument product line and boost its market position in automated molecular testing. This will broaden QIAGEN's offering of automated testing solutions and serve as another catalyst for future growth. In July 2020, Merck KGaA announced the expansion of a new production plant in Buchs for USD 21 million. Merck's reference materials at this plant will be used daily by researchers in testing laboratories worldwide to assist in creating accurate, dependable analytical findings in pharmaceutical, environmental, and food and beverage analysis. Various Leading Lateral Flow Assay Devices that Key Market Leaders Develop Name of the Product Function Key Players BinaxNOW Ag Rapid Antigen Testing for COVID-19 Abbott Laboratories Sofia SARS Antigen Fluorescent Immunoassay Qualitative detection of nucleocapsid protein in SARS-CoV-2 Quidel Corporation Roche cardiac Troponin T sensitive test Diagnosis of myocardial infarction F. Hoffman-La Roche AG CLINITEST® Rapid COVID-19 Antigen Test Rapid testing for COVID-19 Siemens AG VIKIA® HBs Ag Rapid testing for Hepatitis B bioMérieux SA Frequently Asked Question About This Report What are the top trends in the lateral flow assays market? The demand for POC testing and home-based lateral flow assays are top trends in the market. Why is the North America lateral flow assays market growing? The North American lateral flow assays market is growing due to the widespread availability and inexpensive cost of technologically improved lateral flow tests. How big is the lateral flow assays market? The global lateral flow assays market size was $8.76 Bn in 2021 and is predicted to reach $12.85 Bn by 2030, with a CAGR of 4.34%. Which are the top industry players in the lateral flow assays market? The top market players are Abbott Laboratories, Quidel Corporation, F. Hoffman-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Hologic Inc., QIAGEN N.V., and Merck KGaA. What is the lateral flow assays market growth? The global lateral flow assays market is expected to grow at a compound annual growth rate (CAGR) of 4.34% from 2021 to 2030 to reach USD 12.85 billion by 2030. Which region is dominating in the lateral flow assays market? North America currently dominates in the lateral flow assays market. . 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size By bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size By Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Lateral Flow Assays Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, By region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021-2030 (USD Million) 4.5 By End-Use Business Analysis 4.5.1 Market, By End-Use, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021-2030 (USD Million) 4.7 Technique Business Analysis 4.7.1 Market, By Technique, 2021-2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Market Drivers Analysis 4.9.2 Market Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 Market PEST analysis 4.10.2 Market Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technique Analysis 5.11.1. Trends in Technique (2014-2020) 5.11.2. Trends in Technique (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Kits & Reagents 7.3.1. Kits & Reagents Market, 2021-2030 (USD Million) 7.4. Lateral Flow Readers 7.4.1. Lateral Flow Readers Market, 2021-2030 (USD Million) 8. Market: By End-Use Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Clinics 8.3.1. Hospitals and Clinics Market, 2021-2030 (USD Million) 8.4. Diagnostic Laboratories 8.4.1. Diagnostic Laboratories Market, 2021-2030 (USD Million) 8.5. Homecare 8.5.1. Homecare Market, 2021-2030 (USD Million) 8.6. Pharmaceutical and Biotechnology Companies 8.6.1. Pharmaceutical and Biotechnology Companies Market, 2021-2030 (USD Million) 8.7. Others 8.7.1. Others Market, 2021-2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Clinical Testing 9.3.1. Clinical Testing Market, 2021-2030 (USD Million) 9.4. Cardiac Marker Testing 9.4.1. Cardiac Marker Testing Market, 2021-2030 (USD Million) 9.5. Pregnancy and Fertility Testing 9.5.1. Pregnancy and Fertility Testing Market, 2021-2030 (USD Million) 9.6. Cholesterol Testing/Lipid Profile Testing 9.6.1. Cholesterol Testing/Lipid Profile Testing Market, 2021-2030 (USD Million) 9.7. Drugs of Abuse Testing 9.7.1. Drugs of Abuse Testing Market, 2021-2030 (USD Million) 9.8. Others 9.8.1. Others Market, 2021-2030 (USD Million) Market: By Technique Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Sandwich Assay 10.3.1. Sandwich Assay Market, 2021-2030 (USD Million) 10.4. Competitive Assay 10.4.1. Competitive Assay Market, 2021-2030 (USD Million) 10.5. Multiplex Detection Assay 10.5.1. Multiplex Detection Assay Market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By Product, 2021-2030 (USD Million) 11.1.2. North America Market, By End-Use, 2021-2030 (USD Million) 11.1.3. North America Market, By Technique, 2021-2030 (USD Million) 11.1.4. North America Market, By Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By Product, 2021-2030 (USD Million) 11.1.4.1.2. U.S. Market, By End-Use, 2021-2030 (USD Million) 11.1.4.1.3. U.S. Market, By Technique, 2021-2030 (USD Million) 11.1.4.2.Canada 11.1.4.2.1. Canada Market, By Product, 2021-2030 (USD Million) 11.1.4.2.2. Canada Market, By End-Use, 2021-2030 (USD Million) 11.1.4.2.3. Canada Market, By Technique, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By Product, 2021-2030 (USD Million) 11.2.2. Europe Market, By End-Use, 2021-2030 (USD Million) 11.2.3. Europe Market, By Technique, 2021-2030 (USD Million) 11.2.4. Europe Market, By country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By Product, 2021-2030 (USD Million) 11.2.4.1.2. U.K. Market, By End-Use, 2021-2030 (USD Million) 11.2.4.1.3. U.K. Market, By Technique, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By Product, 2021-2030 (USD Million) 11.2.4.2.2. Germany Market, By End-Use, 2021-2030 (USD Million) 11.2.4.2.3. Germany Market, By Technique, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By Product, 2021-2030 (USD Million) 11.2.4.3.2. France Market, By End-Use, 2021-2030 (USD Million) 11.2.4.3.3. France Market, By Technique, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By Product, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By End-Use, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, By Technique, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By Product, 2021-2030 (USD Million) 11.3.2. Asia Pacific Market, By End-Use, 2021-2030 (USD Million) 11.3.3. Asia Pacific Market, By Technique, 2021-2030 (USD Million) 11.3.4. Asia Pacific Market, By country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By Product, 2021-2030 (USD Million) 11.3.4.1.2. China Market, By End-Use, 2021-2030 (USD Million) 11.3.4.1.3. China Market, By Technique, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By Product, 2021-2030 (USD Million) 11.3.4.2.2. India Market, By End-Use, 2021-2030 (USD Million) 11.3.4.2.3. India Market, By Technique, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan Market, By Product, 2021-2030 (USD Million) 11.3.4.3.2. Japan Market, By End-Use, 2021-2030 (USD Million) 11.3.4.3.3. Japan Market, By Technique, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By Product, 2021-2030 (USD Million) 11.3.4.4.2. South Korea Market, By End-Use, 2021-2030 (USD Million) 11.3.4.4.3. South Korea Market, By Technique, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC Market, By End-Use, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC Market, By Technique, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By Product, 2021-2030 (USD Million) 11.4.2. Latin America Market, By End-Use, 2021-2030 (USD Million) 11.4.3. Latin America Market, By Technique, 2021-2030 (USD Million) 11.4.4. Latin America Market, By country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By Product, 2021-2030 (USD Million) 11.4.4.1.2. Brazil Market, By End-Use, 2021-2030 (USD Million) 11.4.4.1.3. Brazil Market, By Technique, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By Product, 2021-2030 (USD Million) 11.4.4.2.2. Mexico Market, By End-Use, 2021-2030 (USD Million) 11.4.4.2.3. Mexico Market, By Technique, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America Market, By Product, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America Market, By End-Use, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America Market, By Technique, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA Market, By Product, 2021-2030 (USD Million) 11.5.2. MEA Market, By End-Use, 2021-2030 (USD Million) 11.5.3. MEA Market, By Technique, 2021-2030 (USD Million) 11.5.4. MEA Market, By Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Abbott Laboratories 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. ProductPortfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Quidel Corporation 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. F. Hoffman-La Roche AG 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Danaher Corporation 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Siemens AG 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Becton, Dickinson and Company 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. BioMérieux SA 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Bio-Rad Laboratories 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Thermo Fisher Scientific, Inc. 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. PerkinElmer Inc. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Hologic Inc. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. QIAGEN N.V. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Merck KGaA 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development List of Tables (62 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Kits & Reagents, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Lateral Flow Readers, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By End-Use, 2021-2030 (USD Million) TABLE 5. MARKET FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Diagnostic Laboratories, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Homecare, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Pharmaceutical and Biotechnology Companies, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY TECHNIQUE, 2021-2030 (USD Million) TABLE 11. MARKET FOR Sandwich Assay , BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Competitive Assay , BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Multiplex Detection Assay, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET, BY Application, 2021-2030 (USD Million) TABLE 15. MARKET FOR Clinical Testing, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Cardiac Marker Testing, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Pregnancy and Fertility Testing , BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Cholesterol Testing/Lipid Profile Testing , BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Drugs of Abuse Testing , BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By End-Use, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY TECHNIQUE, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By End-Use, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY TECHNIQUE, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, By End-Use, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY TECHNIQUE, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, By Application, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY TECHNIQUE, 2021-2030 (USD Million) TABLE 38. Abbott Laboratories: COMPANY SNAPSHOT TABLE 39. Abbott Laboratories: OPERATING SEGMENTS TABLE 40. Quidel Corporation: COMPANY SNAPSHOT TABLE 41. Quidel Corporation: OPERATING SEGMENTS TABLE 41. F. Hoffman-La Roche AG: COMPANY SNAPSHOT TABLE 42. F. Hoffman-La Roche AG: OPERATING SEGMENTS TABLE 43. Danaher Corporation: COMPANY SNAPSHOT TABLE 44. Danaher Corporation: OPERATING SEGMENTS TABLE 45. Siemens AG: COMPANY SNAPSHOT TABLE 46. Siemens AG: OPERATING SEGMENTS TABLE 47. Becton, Dickinson and Company: COMPANY SNAPSHOT TABLE 48. Becton, Dickinson and Company: OPERATING SEGMENTS TABLE 49. BioMérieux SA: COMPANY SNAPSHOT TABLE 50. BioMérieux SA: OPERATING SEGMENTS TABLE 51. Bio-Rad Laboratories: COMPANY SNAPSHOT TABLE 52. Bio-Rad Laboratories: OPERATING SEGMENTS TABLE 53. Thermo Fisher Scientific, Inc.: COMPANY SNAPSHOT TABLE 54. Thermo Fisher Scientific, Inc.: OPERATING SEGMENTS TABLE 55. PerkinElmer Inc.: COMPANY SNAPSHOT TABLE 56. PerkinElmer Inc.: OPERATING SEGMENTS TABLE 57. Hologic Inc.: COMPANY SNAPSHOT TABLE 58. Hologic Inc.: OPERATING SEGMENTS TABLE 59. QIAGEN N.V.: COMPANY SNAPSHOT TABLE 60. QIAGEN N.V.: OPERATING SEGMENTS TABLE 61. Merck KGaA: COMPANY SNAPSHOT TABLE 62. Merck KGaA: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 13 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-Use, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Technique, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Kits & Reagents to Witness Higher CAGR in the Market for Product Segment during Forecast Period. Figure 17 Sandwich Assay to Witness Higher CAGR in the Market for Technique Segment during Forecast Period. Figure 18 Hospitals and Clinics to Witness Higher CAGR in the Market for End-Use Segment during Forecast Period. Figure 19 Clinical Testing to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview